VZV Flashcards

1
Q

Varicella (chickenpox/ shingles) infection is normally mild self-limiting disease. Caused by human herpesvirus-3 DNA virus

Which groups are at high risk of severe/ life-threatening disease?

A

Neonates
Pregnant women
Immunosuppressed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

There are limited supplies of VZIG, so need to decide who requires VZIG, and who can have oral anti-virals.

What is recommendation for -
Pregnant patient - up to 20 weeks
exposed to varicella

A

If varicella antibody negative (no previous exposure)

Give VZIG up to 20 weeks as PEP

Limited evidence on effectiveness of oral antivirals at preventing congenital varicella

If antibody present (VZIG >100mIU/ml), re-assure patient, no PEP required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

There are limited supplies of VZIG, so need to decide who requires VZIG, and who can have oral anti-virals.

What is recommendation for -
Pregnant patient - exposed after 20 weeks

A

VZIG

or

Oral aciclovir 800mg 5x from days 7-14 post-exposure
Valaciclovir 1000mg TDS from days 7-14 post-exposure

Recent guidelines showed no difference in VZIG/ aciclovir

Based on evidence of aciclovir being safe in second/ third trimester, and sub-optimal efficacy of VZIG as PEP in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If pregnant/ neonate/ immunosuppressed exposed to chickenpox, what do you want to know in history, and what blood tests?

A

Ask about history of chickenpox - exposure has >97% probability of developing protective antibodies.

If no history, then test for varicella antibodies.

Ask about exposure - higher risk if contact has exposed shingles, or disseminated shingles

Varicella IgG <100mIU/ml denotes susceptible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

There are limited supplies of VZIG, so need to decide who requires VZIG, and who can have oral anti-virals.

What is recommendation for -
neonate (up to 28 days)

A

VZIG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

There are limited supplies of VZIG, so need to decide who requires VZIG, and who can have oral anti-virals.

What is recommendation for -
healthy patient

A

No treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antiviral treatment starts on day 7 to day 14. If patient were to present on day 12, then still offer a 7 day course of antivirals

What is day of exposure?

Why is treatment started at day 7?

A

Day of exposure is first date patient met contact who had rash

Study showed starting aciclovir immediately associated with higher severity of illness (77%), compared to starting at day 7 (21%)

Chickenpox/ shingles usually develops 10-21 days after exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

There are limited supplies of VZIG, so need to decide who requires VZIG, and who can have oral anti-virals

What is recommended for -
immunosuppressed child

A

First assess does not need VZIG - not neonate

Children <2
- aciclovir 10mg/kg QDS daily, 7-14 days after exposure

Children 2-17

  • aciclovir 10mg/kg QDS daily, 7-14 days after exposure
  • valaciclovir 20mg/kg TDS daily, 7-14 days after exspoure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

There are limited supplies of VZIG, so need to decide who requires VZIG, and who can have oral anti-virals.

What is recommendation for -
immunosuppressed adult

A

Oral aciclovir 800mg QDS from days 7-14 post-exposure
Valaciclovir 1000mg TDS from days 7-14 post-exposure

If severe - may need IV aciclovir.
Malabsorption - may need IV aciclovir
Renal toxicity - may need VZIG

If on long term aciclovir prophylaxis, may require dose to be increased temporarily, from day of onset of rash.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aciclovir/ valacilovir are not licensed for PEP in chickenpox, but their use as treatment is well established.

How does off-label prescribing work?

A

Clinicians able to prescribe medicines outside terms of license, when it is in best interest of the patient on basis of available evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What to do if patient has second exposure to varicella?

A

Investigate as if it was first exposure

Perform further risk assessment
Check VZ IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chickenpox in pregnancy can lead to fetal varicella syndrome (FVS)

What are the symptoms?

A
IUGR
Microcephaly
Cataract
Limb hypoplasia
Skin scarring

Does not appear to increase risk of miscarriage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are side effects of aciclovir/ valaciclovir?

A
Headache
Dizziness
Vomiting
Diarrhoea
Photosensitivity
Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pregnant women present with chickenpox symptoms, what is treatment?

A

Oral aciclovir for 7 days, from day of onset of rash. Any stage of gestation, although caution using aciclovir before 20 weeks

If severe symptoms - IV aciclovir

Secondary treatment of bacterial skin infection

Advise to avoid contact with other people until lesions crusted over - usually 5 days. Infectious for 2 days prior to symptoms developing

VZIG has no benefit once infection established

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Women planning pregnancy, who are varicella antibody negative, what advice to give?

A

Avoid chickenpox/ shingles

In some cases, vaccine for VZV can be given, but not routinely on NHS. If given vaccine, avoid pregnancy for 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When we talk of “exposure” to varicella, what situations constitute exposure - home/ hospital

A

Household contact

Contacts in the same small room (e.g. in a house or classroom or a 2 to 4 bed hospital bay) for a
significant period of time (15 minutes or more)

Face to face contact, for example while having a conversation

Immune-suppressed contacts on large open wards, where air-borne transmission at a distance has
occasionally been reported, particularly in paediatric wards where the degree of contact may be difficult
to define

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

If patient has varicella antibodies, why do we not give VZIG

A

The administration of VZIG is unlikely to confer any additional benefit for patients who already have
varicella antibody (VZV IgG) and therefore VZIG is not recommended for individuals with adequate levels
of VZV IgG. Assessment of susceptibility will depend on the history of previous infection or vaccination

18
Q

What is dosage of VZIG for PEP?

A

0 – 5 Years 250mg
6 – 10 Years 500mg
11 – 14 Years 750mg
15 years and older 1000mg

Given IM
Must be given within 10 days

Does not stop getting infection, but reduces severity of symptoms

19
Q

If VZIG contraindicated, for example cannot give IM injection due to bleeding risk, then what is alternative treatment?

A

intravenous human normal immunoglobulin (IVIG) at a dose of 0.2g per kg body weight (i.e. 4ml/kg for a 5%
solution) instead.

This will produce serum VZV antibody levels equivalent to those achieved with VZIG.

20
Q

Active chickenpox in

healthy adults
pregnancy
neonates
immunosuppressed

What is the treatment?

Do not treat healthy children

A

Aciclovir 800mg 5x for 7 days, from day of onset of rash
If severe symptoms - IV aciclovir

If pregnant <20 weeks, can give aciclovir if benefits outweigh risks

There is no evidence that VZIG is effective in the treatment of disease.

21
Q

How is varicella infection diagnosed?

A

Clinical history - rash 10-21 days after exposure

Culture of vesicular fluid. Inoculate human kidney/ lung cells. Since cannot be asymptomatic, if virus present it indicates active infection

Viral PCR - swabs/ CSF

Serology IgG/ IgM. Detectable after a few days, and peaks at three weeks

Visualization of multinucleated giant cells or herpesvirus virions in tissues by histopathology or electron microscopy does not distinguish between VZV and herpes simplex virus (HSV)

22
Q

What is mechanism of action of aciclovir?

A

Aciclovir phosphorylated by thymidine kinase

Is guanosine analogue, so incoroporated into viral DNA by viral DNA polymerase, causes chain termination

Viral DNA polymerase has a much higher affinity for acyclovir triphosphate than does cellular DNA polymerase, resulting in little incorporation of acyclovir triphosphate into cellular DNA.

23
Q

What is aciclovir bioavailability?

A

15-30% bioavailability

Good penetration including CNS

24
Q

What is aciclovir half life?

A

plasma half-life of acyclovir is 2–3 hours in adults and 3–4 hours in neonates with normal renal function

20 hours in anuric patients.

25
Q

What are benefits of valaciclovir?

A

orally administered prodrug of acyclovir that overcomes the problem of poor oral bioavailability and exhibits improved pharmacokinetic properties

Valacyclovir, the L-valine ester of acyclovir, is well absorbed from the gastrointestinal tract via a stereospecific transporter and undergoes essentially complete first pass conversion in the gut and liver to yield acyclovir and L-valine.

Using this prodrug formulation, the bioavailability of acyclovir is increased to about 54%, yielding peak plasma acyclovir concentrations that are three- to fivefold higher than those achieved with oral administration of the parent compound.

26
Q

What are serious complications of varicella in adults?

A

Pneumonitis

CNS infection - presenting as cerebellar ataxia, encephalitis, transverse myelitis, or stroke syndromes

Hepatitis

Decision to start treatment is based on clinical history/ past medical history/ pregnancy. Minimal benefit of anti-virals in healthy individuals

27
Q

How is VZV transmitted?

A

transmitted by respiratory droplets and by direct personal contact with vesicle fluid or indirectly via fomites (e.g. skin cells, hair, clothing
and bedding)

28
Q

What are initial VZV symptoms?

A

The primary infection is characterised by fever, malaise and a pruritic rash that develops into crops of maculopapules, which become vesicular and crust over before healing

29
Q

How does shingles occur?

A

Following the primary infection, the virus remains dormant in sensory nerve root ganglia but can be
reactivated to cause a vesicular erythematous skin rash in a dermatomal distribution

30
Q

Healthcare worker who has not previously had chickenpox. Exposed when changing dressing for shingles.

What needs to be done?

A

Exclude from patient contact from 8-21 days after exposure - may be incubating

If no symptoms, offer vaccination. Not often used

31
Q

What are contra-indications to varicella vaccination?

A

Pregnant
Immunocompromised
Anaphylaxis to components of vaccine

32
Q

Active VZV infection.

Who should be admitted to hospital for assessment?

A

Serious complications (such as meningitis, encephalitis, or myelitis) are suspected.

The person has shingles in the ophthalmic distribution of the trigeminal nerve, especially those with:
Hutchinson’s sign — a rash on the tip, side, or root of the nose, representing the dermatome of the nasociliary nerve, which is a prognostic factor for subsequent eye inflammation and permanent corneal denervation.

Visual symptoms.

An unexplained red eye.

Immunocompromised

33
Q

Active VZV infection.

When is treatment indicated?

Should be commenced within 72 hours of rash starting

A

Neonate

Pregnant

Immunocompromised

Serious complications (such as meningitis, encephalitis, or myelitis) are suspected.

The person has shingles in the ophthalmic distribution of the trigeminal nerve, especially those with:
Hutchinson’s sign — a rash on the tip, side, or root of the nose, representing the dermatome of the nasociliary nerve, which is a prognostic factor for subsequent eye inflammation and permanent corneal denervation.

Visual symptoms.

An unexplained red eye.

Non-truncal involvement (such as shingles affecting the neck, limbs, or perineum).

Moderate or severe pain.

Moderate or severe rash

Anyone over 50 years old - as they are high risk for post-herpetic neuralgia

Steroids sometimes used in addition to anti-virals - but limited evidence for this

Not required -

  • children who are well
  • adults who are well
34
Q

Active VZV infection.

What drugs are available to manage pain of shingles/ post-herpetic neuralgia?

A

NSAIDS

Amitryptiline

Duloxetine

Gabapentin

Pregabalin

35
Q

Patient on prophlyactic aciclovir for recurrent shingles.

Turns 70, and is eligible for Zostavax vaccine.

Can patient have it?

A

Live vaccine - aciclovir interferes with vaccination response.

Stop aciclovir 48 hours before vaccination
Restart aciclovir 14 days after vaccination

Another option is varicella shingrix vaccine, which uses protein subunit. Do not need to stop aciclovir

36
Q

Varicella exposure

What do we need to know about exposure event?

A

What was the contact -
Household contact
Face-face contact
15 min in same room

Where was rash?
Was rash covered? e.g shingles
Was rash crusted over?

37
Q

What is Ramsay Hunt Syndrome?

A

VZV becomes reactivated in the geniculate ganglion of the VIIth cranial nerve (facial nerve) causing facial paralysis, loss of taste, vestibulocochlear dysfunction and pain

38
Q

What are symptoms and signs of Ramsay Hunt?

A

Pain deep within ear

Tinnitus

Hearing loss - unilateral

Unilateral facial droop

Rash or blisters in ear canal

Rash or blisters on face/ tip of nose (Hutchinson’s sign)

39
Q

What is management of Ramsay Hunt syndrome?

A

Ophthalmology review

Eye pad/ eye lubricants

Treatment within 72 hours improves outcome -
- Aciclovir 800 mg five times a day for seven days (continuing until two days after crusting of lesions in those who are immunocompromised). May need IV aciclovir if retinitis/ optic neuritis

  • topical steroids - as advised by ophthalmology. Limited evidence of efficacy of oral steroids

Corneal transplant if does not heal

40
Q

What is Zoster sine herpet?

A

VZV reactivation without a visible rash

e.g Ramsay Hunt Syndrome - patient can present with facial palsy, but it is actually VZV reactivation

Swab the areas where expect a rash e.g inner ear

41
Q

What are the changes to the Shingles vaccine program in 2023?

A

From September 1st, more people will be eligible for the NHS shingles vaccine - shignrix

Previously the shingles vaccine programme was limited to those aged 70 – 79

from September 2023 eligibility will be extended to include those: -
- who turn 65
- who are aged 50 or over and have a severely weakened immune system

In USA they give Shingrix to all HIV patients regardless of CD4 count